Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers - the Eurodiale study.

Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper NC.

J Diabetes Complications. 2017 Apr 13. pii: S1056-8727(16)31096-0. doi: 10.1016/j.jdiacomp.2017.04.008. [Epub ahead of print]

PMID:
28457703
2.

Cell therapy of critical limb ischemia in diabetic patients - State of art.

Dubský M, Jirkovská A, Bem R, Nemcová A, Fejfarová V, Jude EB.

Diabetes Res Clin Pract. 2017 Apr;126:263-271. doi: 10.1016/j.diabres.2017.02.028. Epub 2017 Feb 27. Review.

PMID:
28288436
3.

Diabetic Foot Infections: an Update in Diagnosis and Management.

Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N.

Curr Diab Rep. 2017 Jan;17(1):3. doi: 10.1007/s11892-017-0831-1. Review.

PMID:
28101794
4.

Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers.

Nelson EA, Wright-Hughes A, Brown S, Lipsky BA, Backhouse M, Bhogal M, Ndosi M, Reynolds C, Sykes G, Dowson C, Edmonds M, Vowden P, Jude EB, Dickie T, Nixon J.

Health Technol Assess. 2016 Nov;20(82):1-176.

5.

Minor amputation does not negatively affect health-related quality of life as compared with conservative treatment in patients with a diabetic foot ulcer: An observational study.

Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jirkovská A, Jude EB, Mauricio D, Piaggesi A, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper N.

Diabetes Metab Res Rev. 2017 Mar;33(3). doi: 10.1002/dmrr.2867. Epub 2016 Nov 30.

PMID:
27792855
6.

Serum 25(OH)D and adipokines levels in people with abdominal obesity.

Karonova T, Belyaeva O, Jude EB, Tsiberkin A, Andreeva A, Grineva E, Pludowski P.

J Steroid Biochem Mol Biol. 2016 Sep 11. pii: S0960-0760(16)30241-2. doi: 10.1016/j.jsbmb.2016.09.005. [Epub ahead of print]

PMID:
27629594
7.

Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.

Ajjan RA, Abougila K, Bellary S, Collier A, Franke B, Jude EB, Rayman G, Robinson A, Singh BM.

Diab Vasc Dis Res. 2016 May;13(3):211-9. doi: 10.1177/1479164115624680. Epub 2016 Mar 21.

PMID:
27000105
8.

Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes.

Dubský M, Jirkovská A, Pagáčová L, Bém R, Němcová A, Fejfarová V, Wosková V, Jude EB.

J Diabetes Res. 2015;2015:369758. doi: 10.1155/2015/369758. Epub 2015 Jul 13.

9.

The Charcot foot as a complication of diabetic neuropathy.

Mascarenhas JV, Jude EB.

Curr Diab Rep. 2014 Dec;14(12):561. doi: 10.1007/s11892-014-0561-6. Review.

PMID:
25354828
10.

Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.

Dubský M, Jirkovská A, Bem R, Fejfarová V, Pagacová L, Nemcová A, Sixta B, Chlupac J, Peregrin JH, Syková E, Jude EB.

Cytotherapy. 2014 Dec;16(12):1733-8. doi: 10.1016/j.jcyt.2014.08.010. Epub 2014 Oct 7.

PMID:
25304666
11.

Differences in level of confidence in diabetes care between different groups of trainees: the TOPDOC diabetes study.

Smith CJ, George JT, Warriner D, McGrane DJ, Rozario KS, Price HC, Wilmot EG, Kar P, Stratton IM, Jude EB, McKay GA.

BMC Med Educ. 2014 Sep 17;14:191. doi: 10.1186/1472-6920-14-191.

12.

RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.

Ndip A, Wilkinson FL, Jude EB, Boulton AJ, Alexander MY.

Diabetologia. 2014 Nov;57(11):2251-60. doi: 10.1007/s00125-014-3348-z. Epub 2014 Aug 12. Review.

PMID:
25112376
13.

A patient with type 2 diabetes and a burning sensation in his feet.

Eleftheriadou I, Tentolouris N, Jude EB.

BMJ. 2014 Jul 31;349:g4658. doi: 10.1136/bmj.g4658. No abstract available.

PMID:
25081249
14.

Delayed diagnosis of Addison's disease: an approach to management.

Mascarenhas JV, Jude EB.

BMJ Case Rep. 2014 Jul 18;2014. pii: bcr2014204005. doi: 10.1136/bcr-2014-204005.

15.

Central pontine myelinolysis: electrolytes and beyond.

Mascarenhas JV, Jude EB.

BMJ Case Rep. 2014 Mar 28;2014. pii: bcr2013203516. doi: 10.1136/bcr-2013-203516.

16.

Role of acupuncture in the management of diabetic painful neuropathy (DPN): a pilot RCT.

Garrow AP, Xing M, Vere J, Verrall B, Wang L, Jude EB.

Acupunct Med. 2014 Jun;32(3):242-9. doi: 10.1136/acupmed-2013-010495. Epub 2014 Mar 21.

PMID:
24657491
17.

Peripheral arterial disease.

Mascarenhas JV, Albayati MA, Shearman CP, Jude EB.

Endocrinol Metab Clin North Am. 2014 Mar;43(1):149-66. doi: 10.1016/j.ecl.2013.09.003. Review.

PMID:
24582096
18.

Health-related quality of life predicts major amputation and death, but not healing, in people with diabetes presenting with foot ulcers: the Eurodiale study.

Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper NC.

Diabetes Care. 2014;37(3):694-700. doi: 10.2337/dc13-1212. Epub 2013 Oct 29.

PMID:
24170755
19.

Role of serum levels of angiogenic cytokines in assessment of angiogenesis after stem cell therapy of diabetic patients with critical limb ischemia.

Dubsky M, Jirkovska A, Bem R, Fejfarova V, Varga M, Kolesar L, Pagacova L, Sykova E, Jude EB.

Cell Transplant. 2014;23(12):1517-23. doi: 10.3727/096368913X674071. Epub 2013 Oct 21.

PMID:
24148204
20.

Pathogenesis and medical management of diabetic Charcot neuroarthropathy.

Mascarenhas JV, Jude EB.

Med Clin North Am. 2013 Sep;97(5):857-72. doi: 10.1016/j.mcna.2013.05.002.

PMID:
23992897

Supplemental Content

Support Center